ATE64416T1 - Die verwendung des gal 1 hefe-promotors. - Google Patents

Die verwendung des gal 1 hefe-promotors.

Info

Publication number: ATE64416T1
Authority: AT; Austria
Prior art keywords: gene; gal; segment; dna; vector
Prior art date: 1983-02-28

Application number

AT84101937T

Other languages

English (en)

Inventor

David Botstein

Ronald Wayne Davis

Gerald Ralph Fink

Alison Taunton-Rigby

Robert Gentry Knowlton

Jen-I Mao

Donald Taylor Moir

Christopher Godfrey Goff

Original Assignee

Collaborative Res Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-02-28

Filing date

1984-02-23

Publication date

1991-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23869556&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE64416(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1984-02-23 Application filed by Collaborative Res Inc filed Critical Collaborative Res Inc

1991-06-15 Application granted granted Critical

1991-06-15 Publication of ATE64416T1 publication Critical patent/ATE64416T1/de

Links

108090000623 proteins and genes Proteins 0.000 abstract 5
CYNAPIVXKRLDER-LBPRGKRZSA-N (2s)-2-benzamido-3-(4-hydroxy-3-nitrophenyl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C=1C=CC=CC=1)C1=CC=C(O)C([N+]([O-])=O)=C1 CYNAPIVXKRLDER-LBPRGKRZSA-N 0.000 abstract 2
108010001498 Galectin 1 Proteins 0.000 abstract 2
102100021736 Galectin-1 Human genes 0.000 abstract 2
240000004808 Saccharomyces cerevisiae Species 0.000 abstract 2
210000000349 chromosome Anatomy 0.000 abstract 2
210000004027 cell Anatomy 0.000 abstract 1
230000002068 genetic effect Effects 0.000 abstract 1
239000013612 plasmid Substances 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
210000005253 yeast cell Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
- C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/94—Saccharomyces
- Y10S435/942—Saccharomyces cerevisiae
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/142—Interferon

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Road Signs Or Road Markings (AREA)
Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
Devices For Indicating Variable Information By Combining Individual Elements (AREA)
Prostheses (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

AT84101937T 1983-02-28 1984-02-23 Die verwendung des gal 1 hefe-promotors. ATE64416T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/470,911 US4661454A (en)	1983-02-28	1983-02-28	GAL1 yeast promoter linked to non galactokinase gene
EP84101937A EP0123811B1 (de)	1983-02-28	1984-02-23	Die Verwendung des GAL 1 Hefe-Promotors

Publications (1)

Publication Number	Publication Date
ATE64416T1 true ATE64416T1 (de)	1991-06-15

Family

ID=23869556

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT84101937T ATE64416T1 (de)	1983-02-28	1984-02-23	Die verwendung des gal 1 hefe-promotors.

Country Status (8)

Country	Link
US (1)	US4661454A (de)
EP (1)	EP0123811B1 (de)
JP (1)	JPS6058077A (de)
AT (1)	ATE64416T1 (de)
CA (1)	CA1283373C (de)
DE (1)	DE3484689D1 (de)
DK (1)	DK97784A (de)
GB (1)	GB2137208B (de)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0128743A3 (de) *	1983-06-07	1985-12-27	Genex Corporation	Expression von Fremdgenen in Hefe
EP0132309A3 (de) *	1983-06-27	1985-12-27	The Board Of Trustees Of The Leland Stanford Junior University	Regulierbares eukaryotisches Promotorelement
IL71555A (en) *	1984-04-15	1992-06-21	State Of Israel Israel Inst Fo	Bovine interferon
DE3578435D1 (de) *	1984-12-06	1990-08-02	Labofina Sa	Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
US5037806A (en) *	1985-02-22	1991-08-06	Monsanto Company	Biologically active method using somatotropins
US4861868A (en)	1985-02-22	1989-08-29	Monsanto Company	Production of proteins in procaryotes
DE3689899T2 (de) *	1985-04-08	1994-09-15	Amgen	Verfahren und hybridpromotor zur steuerung der exogenen gentranskription.
EP0213029B1 (de) *	1985-08-02	1993-09-15	Merck & Co. Inc.	Fermentationsausbeute an exprimiertem Protein
JPH0668B2 (ja) *	1985-08-30	1994-01-05	財団法人化学及血清療法研究所	単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド
US5002876A (en) *	1986-09-22	1991-03-26	Phillips Petroleum Company	Yeast production of human tumor necrosis factor
US5013652A (en) *	1986-10-14	1991-05-07	Genex Corporation	Composite yeast vectors
US5882884A (en) *	1987-06-19	1999-03-16	Lucky Biotech Corporation	Expression of proteinaceous sweeteners in yeast
US5487990A (en) *	1988-07-01	1996-01-30	The General Hospital Corporation	Glucose-regulated promoter of yeast acetyl-CoA hydrolase
US5057419A (en) *	1988-09-22	1991-10-15	Rutgers University	Genetically engineered plasmid and organisms for the production of specialized oils
US5187079A (en) *	1988-12-21	1993-02-16	The Research Foundation Of State University Of New York	Glucose-repressible gene for the regulated expression of proteins and expression vector therefor
AU7586991A (en) *	1990-03-21	1991-10-21	Board Of Regents, The University Of Texas System	Yeast expression vectors
DK0548165T3 (da)	1990-09-13	2001-07-16	Univ Duke	Ekspression af G-proteinkoblede receptorer i gær
JPH04287683A (ja) *	1991-03-14	1992-10-13	Ajinomoto Co Inc	酵母変異株およびそれを利用するペプチドまたは蛋白質　　　　　　　　　　　等の製造方法
GB9226065D0 (en) *	1992-12-14	1993-02-10	Ici Plc	Peptides
DE4303744A1 (de) *	1993-02-09	1994-08-11	Univ Autonoma De Nuevo Leon Mo	Hundewachstumshormon
DE19534120A1 (de)	1995-09-14	1997-03-20	Hoechst Ag	Verwendung von Cytohesin-PH-Peptiden zur Beeinflußung der Adhäsionsfähigkeit von Integrinen
WO1997024457A1 (en)	1995-12-29	1997-07-10	Guilford Pharmaceuticals Inc.	Method and kit for detection of multiple protein interactions
US5886151A (en)	1996-05-03	1999-03-23	Regents Of The University Of Minnesota	Candida albicans integrin-like protein
EP2339002A1 (de)	1996-10-16	2011-06-29	ZymoGenetics, Inc.	Homologe des Fibroblasten-Wachstumsfaktors
US6265186B1 (en)	1997-04-11	2001-07-24	Dsm N.V.	Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces
GB9726897D0 (en) *	1997-12-20	1998-02-18	Zeneca Ltd	Process
DE69941126D1 (de)	1998-09-23	2009-08-27	Zymogenetics Inc	Cytokinerezeptor zalpha11
DK1137773T3 (da)	1998-12-07	2008-12-08	Zymogenetics Inc	Væsktfaktorhomolog ZVEGF3
SI1642972T1 (sl)	1999-01-07	2010-05-31	Zymogenetics Inc	Terapevtske uporabe BR X topnih receptorjev
US7833529B1 (en)	1999-01-07	2010-11-16	Zymogenetics, Inc.	Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
KR100743640B1 (ko)	1999-03-09	2007-07-27	지모제넥틱스, 인코포레이티드	신규한 사이토킨 ｚａｌｐｈａ 11 리간드
EP2241623A3 (de)	1999-07-07	2010-12-01	ZymoGenetics, Inc.	Monoklonaler Antikörper gegen menschlichen Cytokinrezeptor
AU2292601A (en)	1999-12-23	2001-07-03	Zymogenetics Inc.	Novel cytokine zcyto18
EP1278852B1 (de)	2000-05-11	2010-07-07	ZymoGenetics, Inc.	Zsig33-ähnliche peptide
CA2412239C (en)	2000-06-26	2013-05-28	Zymogenetics, Inc.	Cytokine receptor zcytor17
DE60135393D1 (de)	2000-06-30	2008-09-25	Zymogenetics Inc	Allelische Variante des Interferon-ähnlichen Proteins Zcyto21
EP1736545A3 (de)	2000-08-08	2007-03-28	ZymoGenetics, Inc.	Lösliche Zcyctor 11 Cytokinrezeptoren
WO2002053747A1 (fr)	2000-12-28	2002-07-11	Toyota Jidosha Kabushiki Kaisha	Procede de production d'alcool de prenyl
WO2002066516A2 (en)	2001-02-20	2002-08-29	Zymogenetics, Inc.	Antibodies that bind both bcma and taci
BRPI0209933B8 (pt)	2001-05-24	2021-05-25	Zymogenetics Inc	proteína de fusão, e, molécula de ácido nucleico
ES2334338T3 (es)	2001-11-05	2010-03-09	Zymogenetics, Inc.	Antagonistas de il-21.
EP2840089A1 (de)	2002-01-18	2015-02-25	ZymoGenetics, Inc.	Zytokinrezeptor Zyctor17-Multimere
DK1961811T3 (da)	2002-01-18	2010-11-08	Zymogenetics Inc	Cytokinligand til behandling af asthma og luftvejs-hyper-responsivitet
CN1659274A (zh)	2002-04-19	2005-08-24	津莫吉尼蒂克斯公司	细胞因子受体
US20040067532A1 (en)	2002-08-12	2004-04-08	Genetastix Corporation	High throughput generation and affinity maturation of humanized antibody
US7785871B2 (en) *	2002-10-09	2010-08-31	Intrexon Corporation	DNA cloning vector plasmids and methods for their use
US20080050808A1 (en) *	2002-10-09	2008-02-28	Reed Thomas D	DNA modular cloning vector plasmids and methods for their use
EP2251352A1 (de)	2003-08-07	2010-11-17	ZymoGenetics, L.L.C.	Homogene Präparate von IL-28 und IL-29
CN1283792C (zh) *	2003-11-14	2006-11-08	余伟明	生物大分子组分相分离法
ATE517914T1 (de)	2004-03-08	2011-08-15	Zymogenetics Inc	Dimere fusionsproteine und materialien und verfahren zu deren herstellung
JP2007537755A (ja) *	2004-05-18	2007-12-27	イントレクソンコーポレイション	Ｄｎａクローニングベクタープラスミドのダイナミックなベクター構築のための方法
JP2008508310A (ja)	2004-07-29	2008-03-21	ザイモジェネティクス，インコーポレイテッド	がんおよび自己免疫障害を治療するためのｉｌ−２８およびｉｌ−２９の使用法
WO2006013072A2 (en)	2004-08-02	2006-02-09	Basf Plant Science Gmbh	Method for isolation of transcription termination sequences
EP1856156A2 (de)	2005-02-08	2007-11-21	ZymoGenetics, Inc.	Anti-il-20-, anti-il-22- und anti-il-22ra-antikörper und bindungspartner sowie verwendungsverfahren bei entzündungen
EP1891107B1 (de)	2005-05-12	2011-07-06	ZymoGenetics, Inc.	Zusammensetzungen und verfahren zur modulierung von immunreaktionen
WO2007019573A2 (en)	2005-08-09	2007-02-15	Zymogenetics, Inc.	Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules
EP1922080A2 (de) *	2005-08-09	2008-05-21	ZymoGenetics, Inc.	Verfahren zur behandlung von b-zell-malignomen mittels taci-ig-fusionsmolekül
US8153598B2 (en) *	2005-10-19	2012-04-10	Intrexon Corporation	PKD ligands and polynucleotides encoding PKD ligands
BRPI0711823A2 (pt) *	2006-05-15	2012-01-17	Ares Trading Sa	métodos para tratamento de doenças auto-imunes com uma molécula de fusão taci-ig
US20100240597A1 (en)	2007-06-15	2010-09-23	Arkansas State University	Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same
EP3124497B1 (de)	2007-09-14	2020-04-15	Adimab, LLC	Synthetische antikörperbibliotheken mit rationalem design und verwendungen davon
US12529164B2 (en)	2007-09-14	2026-01-20	Adimab, Llc	Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en)	2007-09-14	2014-11-04	Adimab, Llc	Rationally designed, synthetic antibody libraries and uses therefor
WO2009065415A1 (en)	2007-11-21	2009-05-28	Roskilde Universitet	Polypeptides comprising an ice-binding activity
CN101952309A (zh) *	2007-12-21	2011-01-19	Ifxa有限公司	蛋白酶抑制剂
KR101720760B1 (ko) *	2008-01-25	2017-03-28	오르후스 우니베르시테트	Ｉｇｆｂｐ-4에 대한 ｐａｐｐ-ａ 활성의 선택적 엑소사이트 억제
EP2604279A1 (de)	2008-03-27	2013-06-19	ZymoGenetics, Inc.	Zusammensetzungen und Verfahren zur Hemmung von PDGFR-beta und VEGF-A
EP2623112B1 (de)	2008-06-27	2015-03-04	Zymogenetics, Inc.	Lösliche hybride FC-Gamma-Rezeptoren und zugehörige Verfahren
US8822642B2 (en)	2010-06-09	2014-09-02	Zymogenetics, Inc.	Dimeric fusion proteins and related compositions and methods
EP3597764A3 (de)	2012-02-01	2020-05-06	SGI-DNA, Inc.	Material und verfahren zur synthese von fehlerminimierten nukleinsäuremolekülen
WO2014202089A2 (en)	2013-06-18	2014-12-24	Roskilde Universitet	Variants of anti-freeze polypeptides
CN106318942B (zh) *	2015-06-29	2018-12-25	中国科学院大连化学物理研究所	一种半乳糖激酶启动子和终止子及其应用
CN106318943B (zh) *	2015-06-29	2019-03-05	中国科学院大连化学物理研究所	半乳糖激酶启动子和终止子及其应用
KR102440820B1 (ko)	2015-09-08	2022-09-05	테리피온, 인크.	ApoA-1 융합 폴리펩티드 및 관련 조성물 및 방법
WO2017053469A2 (en)	2015-09-21	2017-03-30	Aptevo Research And Development Llc	Cd3 binding polypeptides
WO2018136163A2 (en)	2016-12-09	2018-07-26	Theripion, Inc.	Tandem apoa-1 fusion polypeptides
EP3655439A1 (de)	2017-07-20	2020-05-27	Aptevo Research and Development LLC	An 5t4 und 4-1bb bindende antigenbindende proteine und zugehörige zusammensetzungen und verfahren
SG11202005692WA (en)	2017-12-20	2020-07-29	Harbour Biomed Shanghai Co Ltd	Antibodies binding ctla-4 and uses thereof
ES3039238T3 (en)	2017-12-27	2025-10-20	Imunami Laboratories Pte Ltd	Recombinant polypeptides and methods of use thereof
US10150801B1 (en)	2017-12-27	2018-12-11	Imunami Laboratories Pte. Ltd.	Recombinant polypeptides and methods of use thereof
US10675332B1 (en)	2019-08-26	2020-06-09	Imunami Laboratories Pte. Ltd.	Recombinant polypeptides and methods of use thereof
WO2021040610A1 (en)	2019-08-26	2021-03-04	Imunami Laboratories Pte. Ltd.	Recombinant polypeptides and methods of use thereof
JP7774006B2 (ja)	2020-06-22	2025-11-20	イミュナミラボラトリーズプライベートリミティド	癌治療における使用のための組換えポリペプチド及び組合せ
JP2024507220A (ja)	2021-02-19	2024-02-16	セリピオン，インコーポレイテッド	パラオキソナーゼ融合ポリペプチドならびに関連する組成物および方法
CN120584137A (zh)	2023-01-06	2025-09-02	阿帕特夫研究和发展有限公司	双特异性pd-l1和cd40结合分子以及其用途
WO2024259220A1 (en)	2023-06-15	2024-12-19	Theripion, Inc.	Pon3 and evolved pon1 fusion polypeptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4443539A (en) *	1980-02-05	1984-04-17	The Upjohn Company	Process for preparing bovine growth hormone
US4666847A (en) *	1981-01-16	1987-05-19	Collaborative Research, Inc.	Recombinant DNA means and method
NZ199722A (en) *	1981-02-25	1985-12-13	Genentech Inc	Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
EP0128743A3 (de) *	1983-06-07	1985-12-27	Genex Corporation	Expression von Fremdgenen in Hefe
EP0132309A3 (de) *	1983-06-27	1985-12-27	The Board Of Trustees Of The Leland Stanford Junior University	Regulierbares eukaryotisches Promotorelement

1983
- 1983-02-28 US US06/470,911 patent/US4661454A/en not_active Expired - Lifetime
1984
- 1984-02-23 EP EP84101937A patent/EP0123811B1/de not_active Expired - Lifetime
- 1984-02-23 DE DE8484101937T patent/DE3484689D1/de not_active Expired - Lifetime
- 1984-02-23 AT AT84101937T patent/ATE64416T1/de not_active IP Right Cessation
- 1984-02-24 DK DK97784A patent/DK97784A/da not_active Application Discontinuation
- 1984-02-27 CA CA000448315A patent/CA1283373C/en not_active Expired - Lifetime
- 1984-02-28 GB GB08405129A patent/GB2137208B/en not_active Expired
- 1984-02-28 JP JP59035472A patent/JPS6058077A/ja active Pending

Also Published As

Publication number	Publication date
US4661454A (en)	1987-04-28
DE3484689D1 (de)	1991-07-18
EP0123811A3 (en)	1986-03-26
EP0123811A2 (de)	1984-11-07
EP0123811B1 (de)	1991-06-12
CA1283373C (en)	1991-04-23
JPS6058077A (ja)	1985-04-04
GB2137208B (en)	1987-05-13
GB2137208A (en)	1984-10-03
DK97784A (da)	1984-08-29
GB8405129D0 (en)	1984-04-04
DK97784D0 (da)	1984-02-24

Legal Events

Date	Code	Title	Description
1991-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE64416T1 (de)	1991-06-15	Die verwendung des gal 1 hefe-promotors.
ATE111156T1 (de)	1994-09-15	Transientes expressionssystem zur herstellung von rekombinantem protein.
SE8007998L (sv)	1981-05-22	Forfarande for framstellning av interferon
DK0378382T3 (da)	1997-06-16	Rekombinant DNA-fremgangsmåde og værtsceller
KR920012442A (ko)	1992-07-27	피치아 파스토리스 산성 인산효소 유전자의 dna 단편 및 이를 사용하는 방법
ATE103333T1 (de)	1994-04-15	Hohe proteinsyntheserate in hefe.
DK102886D0 (da)	1986-03-06	Proteinfaktorer
BG60107B2 (bg)	1993-10-29	Метод за получаване на еукариотен полипептид
ATE54167T1 (de)	1990-07-15	Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
DE69331908D1 (de)	2002-06-13	Verfahren zur erhöhung der expression und zur verminderung der expressionsvariabilität von fremdgenen in pflanzenzellen
ATE67242T1 (de)	1991-09-15	Verfahren zur verbesserung der expression von eukaryontenprotein.
DK0749489T3 (da)	1999-08-23	Ekspressionskassette, der omfatter en promotor stammende fra pho4-genet fra Schizosaccharomyces pombe
ATE129287T1 (de)	1995-11-15	Bakterielles kollagenase-gen.
ATE90386T1 (de)	1993-06-15	Verfahren zur expression von genen in hefe, dns- fragmente und plasmide die letztere fragmente enthalten und zur durchfuehrung des verfahrens verwendet werden.
DE58909205D1 (de)	1995-06-08	Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten.
ATE107358T1 (de)	1994-07-15	System der induzierbaren positiven regulation zur verwendung für die herstellung von heterologen proteinen.
ATE85358T1 (de)	1993-02-15	Verfahren zur herstellung von plasminogenaktivatoren in prokaryonten.